Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Non-transformed-thymidine-kinaseless-cell-line-and-its-use-for-testing-tumorigenic-potential-of-genes

 Aqueous alkaline composition
OF THE INVENTION In Formula I a is from 2.5 to 7, preferably from 3 to 6.5, more preferably from 3....


 Stereospecific keto reduction of bicyclooctandione-carboxylic acid esters by microorganisms
What is claimed is: 1. A process for the production of a 3.alpha.-hydroxy prostacyclin intermediate ...


 Automatic sludge extraction and washing device for use in a water treatment settling apparatus
With the above discussion in mind, it is the primary object of the present invention to provide a ...


 Fuel separator system
The present invention is a float actuated control to drain water from a fuel tank without loss of ...


 Methods and nucleic acid sequences for the expression of the cellulose synthase operon
The present invention provides an operon associated with the biosynthesis of cellulose, ...


 Method for preparing adenosine triphosphate
We claim: 1. A method of preparing adenosine triphosphate in an enzyme-catalyzed reaction, said ...


 Cancer detection procedure using an acyl carrier protein
OF THE PREFERRED EMBODIMENT The present diagnostic procedure is based upon the finding that ...


 Process for the preparation of vanillin
What is claimed is: 1. A process for the preparation of vanillin which comprises oxidizing in a ...


 Bioconversion process for the production of vanillin
We claim: 1. A process for the production of vanillin comprising contacting a bioconversion mixture ...


 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
What is claimed is: 1. An isolated polynucleotide comprising a polynucleotide sequence selected ...


 Non-transformed thymidine kinaseless cell line and its use for testing tumorigenic potential of genes

Details
Inventors: Hampar, Berge; Showalter, Stephen D.;
Assignee: The United States of America as represented by the Department of Health (Washington, DC)
Primary Examiner: Wiseman; Thomas G.
Assistant Examiner: Tarcza; John Edward
Attorney, Agent or Firm: Roberts, Jr.; John S.

A non-transformed cell line is produced by treating BALB/c derived 10E2 cells with 5-bromodeoxyuridine and 5-iodo-2'-deoxyuridine to produce thymidine kinaseless cells which upon multiple cloning show a flat epitheloid appearance indicative of their non-transforming potential. These cells are used to determine the tumorigenic transforming potential of any gene by introducing the gene into the cells of the non-transformed cell line along with the Herpes simplex virus thymidine kinase gene which serves as a vehicle for cotransfection. The transformation of the cells is indicative of tumorigenic potential.

DETAILED DESCRIPTION We claim: 1.
A method for the determination of the tumorigenic or morphological transforming potential of a non-thymidine kinase (TK) gene comprising, introducing a non-TK gene and a TK gene into an animal cell line which lacks TK and is non-tumorigenic and not transformed morphologically by co-transformation or transformation of ligated genes, selecting for TK containing cells and, testing the resulting cells for tumorigenic potential in animals or phenotypic expression of morphological transformation in vitro.
2.
A method according to claim 1 where the cell line lacking TK has all the identifying characteristics of ATCC CRL 8085.
3.
A method according to claim 1 where the cell line lacking TK is produced by the process of exposing TK containing cells to at least one pyrimidine analogue capable of selecting for cells which lack TK activity, selecting and isolating a morpholigically non-transformed, non-tumorigenic animal cell line lacking TK and, cloning the resulting isolated cell line.
4.
A method for preparing morphologically non-transformed, non-tumorigenic animal cells which lack thymidine kinase (TK) comprising, exposing TK containing cells to at least one pyrimidine analogue capable of selecting for cells which lack TK activity, selecting and isolating a morphologically non-transformed, non-tumorigenic animal cell line lacking TK and, cloning said isolated cell line.
5.
A method according to claim 4 where the pyrimidine analogues are 5-bromodeoxyuridine and 5-iodo-2-deoxyuridine.
6.
A method according to claim 5 where the cells are exposed to 5-bromodeoxyuridine before exposure to 5-iodo-2-deoxyuridine.
7.
A method according to claim 4 where the concentration of pyrimidine analogue is gradually increased during exposure.
8.
A cell line produced by the process of claim 4, 5, 6 or 7.
9.
A non-transformed, non-tumorigenic thymidine kinase lacking cell line having all the identifying characteristics of ATCC CRL 8085.




Description:
STATEMENT OF PRIOR ART Kit et al, Experimental Cell Research, 31:297-312 (1963) teaches preparation of cells deleted of thymidine kinase



Related patents
  Article with a lyophilized immunoreactive self-adhering coating
I claim: 1. An article useful for immunological determinations which article comprises a carrier material having at least part of one surface thereof physically coated ...
  Method, device and kit for measurement of tissue plasminogen activator activity
Namely, the present invention is characterized by reacting, a solid phase having bound thereto anti t-PA antibody IgG fraction having affinity to a site other than the ...
  Blocked cholecalciferol and dihydrotachysterol 3 derivatives
We have found that cholecalciferol and dihydrotachysterol.sub.3 and their derivatives may be metabolically blocked by the presence of a halo or O-C.sub.1-5 alkyl ...
  4-[(Carboxyl- and sulfamyl-substituted alkyl)-amino] benzoic acids and analogs
OF THE INVENTION The compounds of the invention are new and novel 4-[(carboxyl- and sulfamyl-substituted alkyl)amino]benzoic acids and analogs which have ...
  Vaccine production
What is claimed is: 1. In a process for the controlled manufacture of vaccines wherein cells are grown in a glucose containing nutrient medium and infected with a virus, ...
  Method of fermenting brewer's wort
We claim: 1. The method of preparing an alocholic beverage, comprising the steps of preparing an aqueous fermentable substrate containing fermentable carbohydrates and ...
  Treatment of hemorrhagic shock
I claim: 1. A method of treating shock in humans to reverse the same and elevate blood pressure which comprises intravenously administering to a patient in need thereof ...
  Compositions comprising alkylpolysaccharide detergent surfactant
What is claimed is: 1. A homogeneous granular detergent composition comprising: (1) from about 2% to about 30% of alkylpolysaccharide detergent surfactant having the ...
  Process for the preparation of a mixture of sucrose oxidation products and the use thereof
We claim: 1. A process for the preparation of a mixture of sucrose oxidation products which comprises a salt of sucrosetricarboxylic acid comprising reacting sucrose ...
  Process for making a high density detergent composition from starting detergent ingredients
OF THE PREFERRED EMBODIMENT The present process is used in the production of low dosage detergent agglomerates directly from starting detergent ingredients rather than ...

0.154

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved